Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression

The aim of this study was to determine the raising anticancer effects of resveratrol (Res) on paclitaxel (PA) in non-small cell lung cancer (NSCLC) cell line A549. The 10 µg/ml of Res had no effect on human fetal lung fibroblast MRC-5 cells or on A549 cancer cells and the 5 or 10 µg/ml of PA also ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fanhua, Zhang, Runqi, Zhao, Xudong, Zheng, Guanlin, Wang, Zhou, Wang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587597/
https://www.ncbi.nlm.nih.gov/pubmed/28883751
http://dx.doi.org/10.4196/kjpp.2017.21.5.465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587597/
https://www.ncbi.nlm.nih.gov/pubmed/28883751
http://dx.doi.org/10.4196/kjpp.2017.21.5.465

Ejemplares similares